Curcumin and Doxorubicin Work Together to Fight Breast Cancer
Author Information
Author(s): Muacevic Alexander, Adler John R, Sarkar Esha, Khan Afreen, Ahmad Rumana, Misra Aparna, Raza Syed Tasleem, Mahdi Abbas A
Primary Institution: Era's Lucknow Medical College and Hospital, Era University, Lucknow, IND
Hypothesis
Can curcumin enhance the effectiveness of doxorubicin in treating triple-negative breast cancer cells?
Conclusion
Curcumin enhances the anticancer effects of doxorubicin, leading to increased cell death in breast cancer cells.
Supporting Evidence
- The combination treatment showed a significant increase in apoptosis in MDA-MB-231 cells.
- Curcumin and doxorubicin together caused a notable S-phase cell cycle arrest.
- Gene expression analysis revealed significant upregulation of P53 and other checkpoint regulatory genes.
Takeaway
This study shows that combining curcumin with doxorubicin can help kill more breast cancer cells than using doxorubicin alone.
Methodology
The study used MTT assays to assess cell viability, flow cytometry for apoptosis analysis, and RT-qPCR for gene expression analysis.
Limitations
Using embryonic kidney cells as a control may not fully represent the effects on normal breast tissue.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website